1. Preserving clinical trial integrity during the coronavirus pandemic;McDermott;JAMA
2. Survival Analysis
3. FDA guidance on conduct of clinical trials of medical products during COVID-19 pandemic: guidance for industry, investigators, and institutional review boards. US Food and Drug Administration. Published May 2020. Accessed May 12, 2020. https://www.fda.gov/media/136238/download.
4. Points to consider on implications of Coronavirus disease (COVID-19) on methodological aspects of ongoing clinical trials. European Medicines Agency, Biostatistics Working Group. Published March 25, 2020. Accessed April 21, 2020. https://www.ema.europa.eu/en/documents/scientific-guideline/points-consider-implications-coronavirus-disease-covid-19-methodological-aspects-ongoing-clinical_en.pdf.
5. Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics Guidance for Industry. US Food and Drug Administration. Published December 2018. Accessed March 26, 2020. https://www.fda.gov/media/71195/download.